Pfizer To Acquire BioRexis
The mergers continue! Seems even Pfizer who has gobbled up many company in the past hasn’t had its appetite satiated yet.
Pfizer To Acquire BioRexis - Contract Pharma:
Pfizer will acquire BioRexis, a privately held biopharmaceutical company although no financial details were released. BioRexis is developing drugs for the treatment of type 2 diabetes. BioRexis also has a proprietary protein engineering technology that may be why Pfizer was truly interested in them. Pfizer, like many larger pharmaceutical companies is interested in beefing up their biologicals since these tend to have higher prices and currently no generic competition.
Press Release from BioRexis’ Site
Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
Technorati Tags: Pfizer, pharma M&A, pharmaceutical deals, Biorexis
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
